Dilek Özkaya

9PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Photography, video and lens-based practiceTraditional Chinese medicine and treatmentsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 06, 2026
Psalmotoxin-1, a novel TRPM2 channel antagonist, reduces age-related macular degeneration-caused mitochondrial oxidative damage and apoptosis in human retinal pigment epithelial (ARPE-19) cells.

|Apr 26, 2023
Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line.

Alper Ertuğrul, Dilek Özkaya, Mustafa Nazıroğlu

|Apr 03, 2023
Effect of adalimumab on experimental corneal neovascularization model.

Dilek Özkaya, Umut Karaca, Gülşah Usta Sofu

|Jan 01, 2023
Keratitis following leech therapy for periocular eczematous dermatitis: a case report.

Dilek Özkaya

|Jun 10, 2022
The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.

Dilek Özkaya

|Jan 30, 2022
Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment.

Elçin Süren, Dilek Özkaya, Ersan Çetinkaya

Pageof 2

Frequent Collaborators

3 joint publications

Mustafa Nazıroğlu

2 joint publications

Gülşah Usta

2 joint publications

Umut Karaca

1 joint publications

Mehmet Okan Özkaya